Cargando…
Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
BACKGROUND: Rotavirus gastroenteritis (RVGE) is a frequent disease in young children. The recommended German paediatric immunisation schedule does not currently include rotavirus vaccination. A lack of economic data on the impact of routine vaccination is stated as one of the reasons. As a result, t...
Autores principales: | Knoll, Stefanie, Mair, Christoph, Benter, Ursula, Vouk, Katja, Standaert, Baudouin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831585/ https://www.ncbi.nlm.nih.gov/pubmed/24246029 http://dx.doi.org/10.1186/2191-1991-3-27 |
Ejemplares similares
-
Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012) -
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014) -
Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
por: Rose, Johnie, et al.
Publicado: (2009) -
Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016) -
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
por: Li, Rong-cheng, et al.
Publicado: (2014)